Nintedanib Accord 150 mg soft capsules
Authorisation EU/1/24/1803/007-010 · Accord Healthcare S.L.U.
- Licence holder
- Accord Healthcare S.L.U. (all products →)
- Active substance
- Nintedanib esylate
- Dosage form
- Capsule, soft
- Route of administration
- Oral use
- ATC code
- L01EX09
- First authorised
- 19/04/2024
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Nintedanib esylate: supply and approvals
19 authorised products on the HPRA list contain Nintedanib esylate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 1803. It has been authorised for 2 years (since 19 April 2024). The HPRA list does not say whether it is on sale.
Other medicines with Nintedanib esylate in Ireland
18 other products on the HPRA list contain Nintedanib esylate, from 8 licence holders; 4 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Nintedanib Clonmel Healthcare 100 mg soft capsules | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Nintedanib Clonmel Healthcare 150 mg soft capsules | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Nintedanib Teva 100 mg soft capsules | TEVA GmbH | National authorisation (PA) | Marketed |
| Nintedanib Teva 150 mg soft capsules | TEVA GmbH | National authorisation (PA) | Marketed |
| Nintedanib Accord 100 mg soft capsules | Accord Healthcare S.L.U. | Centralised EU authorisation | Not stated |
| Nintedanib Accordpharma 100 mg soft capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Not marketed |
| Nintedanib Accordpharma 150 mg soft capsules | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Not marketed |
| Nintedanib Clonmel 100 mg soft capsules | Clonmel Healthcare Ltd | National authorisation (PA) | Not marketed |
| Nintedanib Clonmel 150 mg soft capsules | Clonmel Healthcare Ltd | National authorisation (PA) | Not marketed |
| Nintedanib Norton 100 mg soft capsules | Norton Waterford | National authorisation (PA) | Not marketed |
| Nintedanib Norton 150 mg soft capsules | Norton Waterford | National authorisation (PA) | Not marketed |
| Nintedanib Teva GmbH 100 mg Soft Capsules | TEVA GmbH | National authorisation (PA) | Not marketed |
The licence holder
Accord Healthcare S.L.U. holds 181 products on the HPRA list, with 76 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.